DigitalOcean's new leadership drives product-led growth, targeting SMBs with simplicity and cost-effectiveness. Discover ...

Read why restructuring efforts, high competition and past acquisition strategy raise doubts about 3D Systems achieving ...

UBS downgrades Stellantis (STLA) to Neutral, citing U.S. tariffs, market challenges, and reduced EPS forecasts.

Summit Therapeutics is making strides with ivonescimab, but upcoming trial results and financial challenges suggest caution.

Read about Janus Henderson AAA CLO ETF, a CLO fund offering 6% yield with minimal risk, ideal as a short-duration bond proxy.